Literature DB >> 28674241

Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family.

Liwei Guo1, Duan Li, Shuangshuang Dong, Donghao Wan, Baosheng Yang, Yanmei Huang.   

Abstract

Autosomal dominant Alport syndrome (ADAS) accounts for 5% of all cases of Alport syndrome (AS), a primary basement membrane disorder arising from mutations in genes encoding the type IV collagen protein family.Mutations in COL4A3 and COL4A4 genes were reported to be associated with ADAS. In this study, clinical data in a large consanguineous family with seven affected members were reviewed, and genomic DNA was extracted. For mutation screening, all exons of COL4A3 and COL4A4 genes were polymerase chain reaction-amplified and direct sequenced from genomic DNA, and the mutations were analyzed by comparing with members in this family, 100 ethnicitymatched controls and the sequence of COL4A3 and COL4A4 genes from GenBank. A novel mutation determining a nucleotide change was found, i.e. c.4195 A>T (p.Met1399Leu) at 44th exon of COL4A4 gene, and this mutation showed heterozygous in all patients of this family. Also a novel intron mutation (c.4127+11 C>T) was observed at COL4A4 gene. Thus the novel missense mutation c.4195 A>T (p.Met1399Leu) and the intron mutation (c.4127+11 C>T) at COL4A4 gene might be responsible for ADAS of this family. Our results broadened the spectrum of mutations in COL4A4 and had important implications in the diagnosis, prognosis, and genetic counselling of ADAS.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28674241     DOI: 10.1007/s12041-017-0786-7

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  15 in total

1.  Autosomal dominant Alport's syndrome: study of a large Tunisian family.

Authors:  M Kharrat; S Makni; K Makni; K Kammoun; K Charfeddine; H Azaeiz; F Jarraya; M Ben Hmida; M C Gubler; H Ayadi; J Hachicha
Journal:  Saudi J Kidney Dis Transpl       Date:  2006-09

2.  Identification of a new mutation in the alpha4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemia.

Authors:  M Ciccarese; D Casu; F Ki Wong; R Faedda; S Arvidsson; G Tonolo; H Luthman; A Satta
Journal:  Nephrol Dial Transplant       Date:  2001-10       Impact factor: 5.992

3.  Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation.

Authors:  F T van der Loop; L Heidet; E D Timmer; B J van den Bosch; A Leinonen; C Antignac; J A Jefferson; A P Maxwell; L A Monnens; C H Schröder; H J Smeets
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

4.  Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4).

Authors:  J A Jefferson; H H Lemmink; A E Hughes; C M Hill; H J Smeets; C C Doherty; A P Maxwell
Journal:  Nephrol Dial Transplant       Date:  1997-08       Impact factor: 5.992

5.  Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.

Authors:  Chiara Pescucci; Francesca Mari; Ilaria Longo; Paraskevi Vogiatzi; Rossella Caselli; Elisa Scala; Cataldo Abaterusso; Rosanna Gusmano; Marco Seri; Nunzia Miglietti; Elena Bresin; Alessandra Renieri
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

6.  Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome.

Authors:  E Boye; G Mollet; L Forestier; L Cohen-Solal; L Heidet; P Cochat; J P Grünfeld; J B Palcoux; M C Gubler; C Antignac
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

7.  Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.

Authors:  Elena Marcocci; Vera Uliana; Mirella Bruttini; Rosangela Artuso; Margherita Cirillo Silengo; Marlenka Zerial; Franco Bergesio; Antonio Amoroso; Silvana Savoldi; Marco Pennesi; Daniela Giachino; Giuseppe Rombolà; Giovanni Battista Fogazzi; Cristina Rosatelli; Ciro Dresch Martinhago; Mario Carmellini; Roberta Mancini; Giuseppina Di Costanzo; Ilaria Longo; Alessandra Renieri; Francesca Mari
Journal:  Nephrol Dial Transplant       Date:  2009-01-07       Impact factor: 5.992

8.  Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.

Authors:  M J Nabais Sá; H Storey; F Flinter; M Nagel; S Sampaio; R Castro; J A Araújo; M A Gaspar; C Soares; A Oliveira; A C Henriques; A G da Costa; C P Abreu; P Ponce; R Alves; L Pinho; S E Silva; C P de Moura; L Mendonça; F Carvalho; M Pestana; S Alves; F Carvalho; J P Oliveira
Journal:  Clin Genet       Date:  2014-11-10       Impact factor: 4.438

9.  Alport syndrome. Molecular genetic aspects.

Authors:  Jens Michael Hertz
Journal:  Dan Med Bull       Date:  2009-08

10.  Frequency of COL4A3/COL4A4 mutations amongst families segregating glomerular microscopic hematuria and evidence for activation of the unfolded protein response. Focal and segmental glomerulosclerosis is a frequent development during ageing.

Authors:  Louiza Papazachariou; Panayiota Demosthenous; Myrtani Pieri; Gregory Papagregoriou; Isavella Savva; Christoforos Stavrou; Michael Zavros; Yiannis Athanasiou; Kyriakos Ioannou; Charalambos Patsias; Alexia Panagides; Costas Potamitis; Kyproula Demetriou; Marios Prikis; Michael Hadjigavriel; Maria Kkolou; Panayiota Loukaidou; Androulla Pastelli; Aristos Michael; Akis Lazarou; Maria Arsali; Loukas Damianou; Ioanna Goutziamani; Andreas Soloukides; Lakis Yioukas; Avraam Elia; Ioanna Zouvani; Polycarpos Polycarpou; Alkis Pierides; Konstantinos Voskarides; Constantinos Deltas
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

View more
  3 in total

1.  Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population.

Authors:  Lifeng Tang; Xuemei Zhong; Hui Gong; Maimaitiaili Tuerxun; Tao Ma; Jie Ren; Chengxin Xie; Aifang Zheng; Zulipikaer Abudureheman; Ayiguzali Abudukadeer; Paierda Aini; Subinuer Yilamujiang; Li Li
Journal:  BMC Pulm Med       Date:  2022-05-05       Impact factor: 3.320

2.  Associations of high-altitude polycythemia with polymorphisms in PIK3CD and COL4A3 in Tibetan populations.

Authors:  Xiaowei Fan; Lifeng Ma; Zhiying Zhang; Yi Li; Meng Hao; Zhipeng Zhao; Yiduo Zhao; Fang Liu; Lijun Liu; Xingguang Luo; Peng Cai; Yansong Li; Longli Kang
Journal:  Hum Genomics       Date:  2018-07-27       Impact factor: 4.639

3.  New Insights into Renal Failure in a Cohort of 317 Patients with Autosomal Dominant Forms of Alport Syndrome: Report of Two Novel Heterozygous Mutations in COL4A3.

Authors:  José María García-Aznar; Luis De la Higuera; Lara Besada Cerecedo; Nerea Paz Gandiaga; Ana Isabel Vega; Gema Fernández-Fresnedo; Domingo González-Lamuño
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.